口腔微生物组在阿尔茨海默氏病中的标记
Argul Issilbayeva1, Aiym Kaiyrlykyzy1, Elizaveta Vinogradova1
1Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana Z05H0P9, Kazakhstan.
Pathogens (Basel, Switzerland)
|March 27, 2024
概括
阿尔茨海默病 (AD) 患者的口腔微生物组显示出更高的微生物多样性,其中关键细菌水平发生变化,如Firmicutes和Bacteroidetes. 牙周炎相关细菌在阿尔茨海默病患者中减少,这表明口腔健康和认知能力下降之间存在联系.
科学领域:
- 微生物学 微生物学
- 神经科学是一个神经科学.
- 老年学是一门学科.
背景情况:
- 牙周病和口腔微生物组的改变越来越多地与认知能力下降有关.
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,具有重大的全球影响.
- 了解口腔微生物组在阿尔茨海默氏病变发生过程中的作用,对于潜在的治疗策略至关重要.
研究的目的:
- 研究和比较中亚阿尔茨海默病患者与健康老年人的口腔微生物群多样性.
- 在口腔微生物群中识别与AD相关的特定细菌种群和代谢途径.
主要方法:
- 采用了病例控制研究设计,比较了来自AD患者 (n=64) 和健康对照组 (n=71) 的口腔微生物样本.
- 使用16S核糖体RNA测序来描述细菌的分类组合.
- 线性差异分析效果大小 (LEfSe) 用于在属级别的差异丰度分析.
主要成果:
- 与健康对照组相比,AD患者表现出更高的口腔微生物多样性.
- 观察到细菌族群的显著变化:在AD组中,Firmicutes的增加和Bacteroidetes的减少.
- 两组之间发现了基因层构成和代谢途径的特定差异,在AD患者中,牙周炎相关细菌显著减少.
结论:
- 在阿尔茨海默病患者中,口腔微生物组的组成发生了显著的变化.
- 特定的细菌种群和代谢途径在AD患者和健康个体之间有所不同.
- 需要进一步的研究,以充分阐明口腔微生物组与AD之间的复杂关系.
相关概念视频
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184


